BSE filing, NSE: KALPATARU. Summary written from the filing by ALFA Finder's alert engine.
Kalpataru Ltd: key numbers
- Share price
- ₹247.10
- Market cap
- ₹5,088 Cr
- Revenue (annual)
- ₹3,480 Cr
- Net profit (annual)
- ₹93.71 Cr
- P/E (TTM)
- 43.6×Sector 34.0×
- Promoter holding
- 81.33%-0.01% QoQ
- FII holding
- 5.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalpataru Ltd
All →Kalpataru Board Meeting Date
Kalpataru Ltd scheduled its Board meeting for 29 Oct 2026 to consider Q2 and H1 2026 financial results. No decision has been taken yet.
Kalpataru Other Announcement
Kalpataru Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. The filing reports updated promoter group holdings.
Kalpataru Legal & Regulatory
Kalpataru Limited's subsidiary, Kalpataru Properties, received a GST show-cause notice for ₹73.85 Crore. The company considers the demand unsustainable and expects no material financial impact.
- Value
- ₹73.85 Cr
Kalpataru Business Update
Kalpataru Limited reported provisional H1 FY27 pre-sales of Rs. 2,587 Crore and collections of Rs. 2,554 Crore, and announced the launch of project Kalpataru Elaara.
Kalpataru Legal & Regulatory
Kalpataru Limited's subsidiary, Ananta Landmarks Private Limited, received a Rs. 14.00 Crore GST show cause notice. The company intends to contest the demand for FY 2022-23.
- Value
- ₹14.00 Cr
Kalpataru Legal & Regulatory
Kalpataru's subsidiary Abacus Real Estate faces a GST appeal for Rs.13.57 Crore tax demand at the Appellate Tribunal. The company states no material financial impact on operations.
- Value
- ₹13.57 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.